A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 32 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NICHD NIH HHS
Grant: R01 HD095880
National Institutes of Health
Grant: 5R01HD095880-02
Development of a mucosal, polyanhydride-based nanoparticle vaccine for use against RSV infection in the neonate
FWCI
3.43
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals